文献速递精神分裂症与精神病性障碍

精神分裂症中的色氨酸分解代谢或犬尿氨酸通路:荟萃分析揭示中枢、血清和血浆区室间的分离

The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments.
PubMed 文献 · Mol Psychiatry · 2022-04-14

该系统综述检索了PubMed、Web of Science和Google Scholar从建库至2021年8月的文献,纳入61项研究(2813例患者,2948例健康对照),荟萃分析精神分裂症与中枢神经系统及外周血中色氨酸分解代谢物的关联。中枢神经系统中犬尿氨酸/色氨酸比值、犬尿喹啉酸/犬尿氨酸+色氨酸比值、犬尿喹啉酸和犬尿氨酸显著升高,3OH-犬尿氨酸+犬尿氨酸-3-单加氧酶/犬尿氨酸比值显著降低;外周血中仅血清犬尿氨酸/色氨酸比值升高,血浆中无显著变化。

要点

  • 中枢神经系统中KYN/TRP比值显著升高(SMD=0.769,95%CI 0.456-1.082,p<0.001)
  • 中枢神经系统中KA/KYN+TRP比值显著升高(SMD=0.697,95%CI 0.478-0.917)
  • 仅血清KYN/TRP比值升高(SMD=0.211,95%CI 0.056-0.366,p=0.007),血浆无显著变化

核心结论

  • 精神分裂症伴随中枢神经系统和血清中IDO活性增加,中枢神经系统中KMO活性降低且向KA产生偏移。
  • 该中枢TRYCATs谱提示神经保护、负性免疫调节和抗炎效应。
  • 外周血TRYCATs水平与中枢发现分离,仅血清IDO活性轻度增加。

研究设计与样本

  • 系统综述检索PubMed、Web of Science和Google Scholar从建库至2021年8月的文献。
  • 纳入61项研究,包括2813例患者和2948例健康对照。
  • 对精神分裂症与中枢神经系统及外周血中TRYCATs的关联进行荟萃分析。

主要发现

  • 中枢神经系统中KYN/TRP比值显著升高(SMD=0.769,95%CI 0.456-1.082,p<0.001)。
  • 中枢神经系统中KA/KYN+TRP比值显著升高(SMD=0.697,95%CI 0.478-0.917)。
  • 中枢神经系统中KA升高(SMD=0.646,95%CI 0.422-0.909),KYN升高(SMD=1.238,95%CI 0.590-1.886)。
  • 中枢神经系统中3HK+KMO/KYN比值显著降低(SMD=-1.089,95%CI -1.682至-0.496)。
  • 血清KYN/TRP比值升高(SMD=0.211,95%CI 0.056-0.366,p=0.007),血浆中无显著升高。

关键数值与推荐

  • 中枢神经系统中KYN/TRP、KYN+KA/TRP、3HK+KMO/KYN、KA和KYN水平在中枢与外周血间以及血清与血浆KYN间存在显著差异。
  • 基于KYN、3HK、吡啶甲酸、黄尿酸和喹啉酸的神经毒性复合评分无显著升高。

临床怎么用

  • 血清KYN/TRP比值是中枢TRYCATs发现中唯一有用的外周标志物,但仅表现为轻度增加。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The tryptophan catabolite (TRYCAT) pathway is implicated in the pathophysiology of schizophrenia (SCZ) since the rate-limiting enzyme indoleamine-dioxygenase (IDO) may be induced by inflammatory and oxidative stress mediators. This systematic review searched PubMed, Web of Science, and Google Scholar for papers published from inception until August 2021 and meta-analyzed the association between SCZ and TRYCATs in the central nervous system (CNS) and peripheral blood. We included 61 studies comprising 2813 patients and 2948 healthy controls. In the CNS we found a significant (p < 0.001) increase in the kynurenine/tryptophan (KYN/TRP) (standardized mean difference, SMD = 0.769, 95% confidence interval, CI: 0.456; 1.082) and kynurenic acid (KA)/KYN + TRP (SMD = 0.697, CI: 0.478-0.917) ratios, KA (SMD = 0.646, CI: 0.422; 0.909) and KYN (SMD = 1.238; CI: 0.590; 1.886), while the 3OH-kynurenine (3HK) + KYN-3-monooxygenase (KMO)/KYN ratio was significantly reduced (SMD = -1.089, CI: -1.682; -0.496). There were significant differences between KYN/TRP, (KYN + KA)/TRP, (3HK + KMO)/KYN, KA, and KYN levels among the CNS and peripheral blood, and among serum and plasma KYN. The only useful peripheral marker of CNS TRYCATs findings was the increased KYN/TRP ratio in serum (SMD = 0.211, CI: 0.056; 0.366, p = 0.007), but not in plasma. There was no significant increase in a neurotoxic composite score based on KYN, 3HK, and picolinic, xanthurenic, and quinolinic acid. SCZ is accompanied by increased IDO activity in the CNS and serum, and reduced KMO activity and a shift towards KA production in the CNS. This CNS TRYCATs profile indicates neuroprotective, negative immunoregulatory and anti-inflammatory effects. Peripheral blood levels of TRYCATs are dissociated from CNS findings except for a modest increase in serum IDO activity.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Almulla AF, Vasupanrajit A, Tunvirachaisakul C, et al. The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments. Mol Psychiatry. 2022. PMID: 35422466. doi:10.1038/s41380-022-01552-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。